MEDI 23-Multivalent muscarinic antagonists for the treatment of overactive bladder (OAB)

被引：0

作者：

Hughes, Adam D. ^{[1
]}

Chin, Kay H. ^{[2
]}

Hegde, Sharath S. ^{[3
]}

Husfeld, Craig O. ^{[1
]}

Jasper, Jeffrey R. ^{[2
]}

Ji, Yuhua ^{[1
]}

King, Kristin E. ^{[2
]}

Lee, Tae Weon ^{[2
]}

Li, Li ^{[1
]}

Mammen, Mathai ^{[2
]}

McNamara, Alexander J. ^{[3
]}

Mischki, Trevor K. ^{[1
]}

Obedencio, Glenmar P. ^{[3
]}

Pulido-Rios, Tess ^{[3
]}

Steinfeld, Tod ^{[2
]}

Sweazey, Shelley M. ^{[3
]}

Wilson, Richard D. ^{[1
]}

机构：

[1] Theravance Inc, Med Chem, San Francisco, CA 94080 USA

[2] Theravance Inc, Mol & Cellular Biol, San Francisco, CA 94080 USA

[3] Theravance Inc, Pharmacol, San Francisco, CA 94080 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 234卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

23-MEDI

引用

页数：1

共 50 条

[1] Muscarinic receptor antagonists in the treatment of overactive bladder
Chapple, CR
UROLOGY, 2000, 55 (5A) : 33 - 46
[2] Muscarinic receptor antagonists for overactive bladder
Abrams, Paul
Andersson, Karl-Erik
BJU INTERNATIONAL, 2007, 100 (05) : 987 - 1006
[3] Treatment of the overactive bladder syndrome with muscarinic receptor antagonists - a matter of metabolites?
Michel, Martin C.
Hegde, Sharath S.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 374 (02) : 79 - 85
[4] Treatment of the overactive bladder syndrome with muscarinic receptor antagonists - a matter of metabolites?
Martin C. Michel
Sharath S. Hegde
Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, 374 : 79 - 85
[5] Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB)
El-Zawahry, Ahmed
CURRENT UROLOGY REPORTS, 2019, 20 (06)
[6] Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB)
Ahmed El-Zawahry
Current Urology Reports, 2019, 20
[7] Muscarinic receptor antagonists for overactive bladder treatment: does one fit all?
Witte, Lambertus P. W.
Mulder, Wilhemina M. C.
de la Rosette, Jean J. M. C. H.
Michel, Martin C.
CURRENT OPINION IN UROLOGY, 2009, 19 (01) : 13 - 19
[8] Research and Development of Solifenacin for the Treatment of Overactive Bladder (OAB)
Naito, Ryo
Sato, Shuichi
Takaoka, Kouji
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2012, 70 (10) : 1011 - 1017
[9] Flexible dose fesoterodine in the treatment of overactive bladder (OAB)
Tubaro, Andrea
De Nunzio, Cosimo
BJU INTERNATIONAL, 2013, 112 (03) : 281 - 282
[10] AN ECONOMIC EVALUATION OF FESOTERODINE IN THE TREATMENT OF OVERACTIVE BLADDER (OAB) IN KOREA
Jo, C.
Lee, S. J.
VALUE IN HEALTH, 2009, 12 (03) : A200 - A200

← 1 2 3 4 5 →